From 2008 to 2019, the company’s revenue grew 225 percent and its U.S. surgical case volumes increased 184 percent.
The musculoskeletal implant development and commercialization company has reported positive organic growth for 13 consecutive years.
More articles on devices:
DePuy Synthes holds 19% of minor orthopedic device market – 3 takeaways
Globus Medical builds on 15 years of expandable devices with Fortify VA: 4 notes
UC San Diego Health purchases Mazor X robot for spine surgery: 4 details
